Portland Investment Counsel’s BeOne Medicines Ltd ONC Stock Holding History

Portland Investment Counsel’s Portfolio ONC Stock Details ONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$891K	Hold	3,000	–	–	0.29%	36
2025 Q4	$911K	Hold	3,000	–	–	0.27%	36
2025 Q3	$1.02M	Hold	3,000	–	–	0.28%	30
2025 Q2	$724K	Hold	3,000	–	–	0.21%	35
2025 Q1	$817K	Hold	3,000	–	–	0.25%	25
2024 Q4	$554K	Hold	3,000	–	–	0.14%	39
2024 Q3	$674K	Buy	3,000 +1,000	+50%	+$180K	0.24%	33
2024 Q2	$285K	Buy	2,000 +500	+33%	+$77.1K	0.1%	45
2024 Q1	$27.2K	Buy	+1,500	New	+$242K	8.18%	2

Other funds holding ONC

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Portland Investment Counsel's ONC Position: Q1 2026 in Review

Portland Investment Counsel held its BeOne Medicines Ltd (ONC) position steady in Q1 2026 at 3,000 shares worth $891K. The position accounts for 0.29% of the portfolio, ranked #36.

Portland Investment Counsel first reported a position in ONC in Q1 2024 and has held it in 9 quarters since. The position peaked at $1.02M in Q3 2025. 282 funds tracked by Wall St. Rank hold ONC as of Q1 2026.

Portland Investment Counsel held 3,000 shares of BeOne Medicines Ltd worth $891K as of Q1 2026.
Portland Investment Counsel left its BeOne Medicines Ltd share count unchanged in Q1 2026.
BeOne Medicines Ltd made up 0.29% of Portland Investment Counsel's portfolio in Q1 2026, its #36 holding.
Portland Investment Counsel first reported a position in BeOne Medicines Ltd in Q1 2024 and has held it in 9 quarters since.
Portland Investment Counsel's BeOne Medicines Ltd position peaked at $1.02M in Q3 2025.
282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q1 2026.

Based on Portland Investment Counsel's 13F filing for Q1 2026, filed 14 May 2026.